Risk factors for false-negative T-SPOT.TB assay results in patients with pulmonary and extra-pulmonary TB

Journal of Infection

Volumn 70, Issue 4, 2015, Pages 367-380

  Pan, Liping ^a   Jia, Hongyan ^a   Liu, Fei ^a   Sun, Huishan ^a   Gao, Mengqiu ^a   Du, Fengjiao ^a   Xing, Aiying ^a   Du, Boping ^a   Sun, Qi ^a   Wei, Rongrong ^a   Gu, Shuxiang ^a   Zhang, Zongde ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Extra pulmonary TB; False negative; Pulmonary TB; Risk factor; T SPOT.TB

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BODY MASS; CHILD; CHINA; CYTOKINE RESPONSE; DISEASE DURATION; ENZYME LINKED IMMUNOSPOT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; INTERFERON PRODUCTION; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OBESITY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHINA; ENZYME-LINKED IMMUNOSPOT ASSAY; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; OVERWEIGHT; PROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84925934750     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.12.018     Document Type: Article

References (82)

1. World Health Organization, Global Tuberculosis Report 2013.
2. Brodie D., Schluger N.W. The diagnosis of tuberculosis. Clin Chest Med 2005, 26:247-271.
3. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184.
4. Hughes R., Wonderling D., Li B., Higgins B. The cost effectiveness of nucleic acid amplification techniques for the diagnosis of tuberculosis. Respir Med 2012, 106:300-307.
5. Norbis L., Alagna R., Tortoli E., Codecasa L.R., Migliori G.B., Cirillo D.M. Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis. Expert Rev Anti Infect Ther 2014, 12:633-647.
6. Diel R., Goletti D., Ferrara G., Bothamley G., Cirillo D., Kampmann B., et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011, 37:88-99.
7. Diel R., Loddenkemper R., Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010, 137:952-968.
8. Chen J., Zhang R., Wang J., Liu L., Zheng Y., Shen Y., et al. Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS One 2011, 6:e26827.
9. Dai Y., Feng Y., Xu R., Xu W., Lu W., Wang J. Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis 2012, 31:3127-3137.
10. Dheda K., van Zyl Smit R., Badri M., Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009, 15:188-200.
11. Santin M., Munoz L., Rigau D. Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS One 2012, 7:e32482.
12. Sester M., Sotgiu G., Lange C., Giehl C., Girardi E., Migliori G.B., et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011, 37:100-111.
13. Metcalfe J.Z., Everett C.K., Steingart K.R., Cattamanchi A., Huang L., Hopewell P.C., et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 2011, 204(Suppl. 4):S1120-S1129.
14. Fan L., Chen Z., Hao X.H., Hu Z.Y., Xiao H.P. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol 2012, 65:456-466.
15. Lalvani A., Pareek M. Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin 2010, 28:245-252.
16. Kobashi Y., Mouri K., Yagi S., Obase Y., Fukuda M., Miyashita N., et al. Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med 2008, 47:237-243.
17. Jia H., Pan L., Qin S., Liu F., Du F., Lan T., et al. Evaluation of interferon-gamma release assay in the diagnosis of osteoarticular tuberculosis. Diagn Microbiol Infect Dis 2013, 76:309-313.
18. Kang Y.A., Lee H.W., Hwang S.S., Um S.W., Han S.K., Shim Y.S., et al. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007, 132:959-965.
19. Feng Y., Diao N., Shao L., Wu J., Zhang S., Jin J., et al. Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis. PLoS One 2012, 7:e32652.
20. Cho O.H., Park S.J., Park K.H., Chong Y.P., Sung H., Kim M.N., et al. Diagnostic usefulness of a T-cell-based assay for osteoarticular tuberculosis. J Infect 2010, 61:228-234.
21. Chee C.B., Gan S.H., Khinmar K.W., Barkham T.M., Koh C.K., Liang S., et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol 2008, 46:1935-1940.
22. Jeon Y.L., Nam Y.S., You E., Yang J.J., Kim M.J., Cho S.Y., et al. Factors influencing discordant results of the QuantiFERON-TB Gold In-Tube test in patients with active TB. J Infect 2013, 67:288-293.
23. Hang N.T., Lien L.T., Kobayashi N., Shimbo T., Sakurada S., Thuong P.H., et al. Analysis of factors lowering sensitivity of interferon-gamma release assay for tuberculosis. PLoS One 2011, 6:e23806.
24. Kim E.Y., Park M.S., Kim Y.S., Kim S.K., Chang J., Kang Y.A. Risk factors for false-negative results of QuantiFERON-TB Gold In-Tube assay in non-HIV-infected patients with culture-confirmed tuberculosis. Diagn Microbiol Infect Dis 2011, 70:324-329.
25. Kiwon C., Eunha C., Soohoon K., Sanghyuk I., In S., Sookhee S., et al. Factors associated with indeterminate and false negative results of QuantiFERON-TB Gold In-Tube test in active tuberculosis. Tuberc Respir Dis 2012, 72:416-425.
26. Kobashi Y., Shimizu H., Ohue Y., Mouri K., Obase Y., Miyashita N., et al. False negative results of QuantiFERON TB-2G test in patients with active tuberculosis. Jpn J Infect Dis 2009, 62:300-302.
27. Liao C.H., Lai C.C., Tan C.K., Chou C.H., Hsu H.L., Tasi T.H., et al. False-negative results by enzyme-linked immunospot assay for interferon-gamma among patients with culture-confirmed tuberculosis. J Infect 2009, 59:421-423.
28. Lee Y.M., Park K.H., Kim S.M., Park S.J., Lee S.O., Choi S.H., et al. Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis. Infection 2013, 41:1089-1095.
29. Bumbacea D., Arend S.M., Eyuboglu F., Fishman J.A., Goletti D., Ison M.G., et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J 2012, 40:990-1013.
30. Cantini F., Niccoli L., Goletti D. Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-alpha (TNF-alpha) targeted biologics and recently licensed TNF-alpha inhibitors: data from clinical trials and national registries. JRheumatol Suppl 2014, 91:56-64.
31. Goletti D., Sanduzzi A., Delogu G. Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol Suppl 2014, 91:24-31.
32. Sester M., van Leth F., Bruchfeld J., Bumbacea D., Cirillo D.M., Gorek Dilektasli A., et al. Risk assessment of tuberculosis in immunocompromised patients - a TBNET study. Am J Respir Crit Care Med 2014, 190:1168-1176.
33. Dewan P.K., Grinsdale J., Kawamura L.M. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007, 44:69-73.
34. Ak O., Dabak G., Ozer S., Saygi A., Dabak R. The evaluation of the Quantiferon-TB Gold test in pulmonary and extrapulmonary tuberculosis. Jpn J Infect Dis 2009, 62:149-151.
35. Kobashi Y., Mouri K., Miyashita N., Okimoto N., Matsushima T., Kageoka T., et al. QuantiFERON TB-2G test for patients with active tuberculosis stratified by age groups. Scand J Infect Dis 2009, 41:841-846.
36. Kobashi Y., Mouri K., Yagi S., Obase Y., Miyashita N., Okimoto N., et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008, 133:1196-1202.
37. Lee J.E., Kim H.J., Lee S.W. The clinical utility of tuberculin skin test and interferon-gamma release assay in the diagnosis of active tuberculosis among young adults: a prospective observational study. BMC Infect Dis 2011, 11:96.
38. Connell T.G., Curtis N., Ranganathan S.C., Buttery J.P. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006, 61:616-620.
39. Machingaidze S., Wiysonge C.S., Gonzalez-Angulo Y., Hatherill M., Moyo S., Hanekom W., et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011, 30:694-700.
40. Inal A., Koc B., Bircan H.Y., Ogan E., Yavuz A., Kemik O. The effects of aging on lymphocyte subgroups in males and females. Med Sci Monit Basic Res 2014, 20:93-96.
41. Tavares S.M., Junior Wde L., Lopes E.S.M.R. Normal lymphocyte immunophenotype in an elderly population. Rev Bras Hematol Hemoter 2014, 36:180-183.
42. Vesosky B., Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunol Rev 2005, 205:229-243.
43. Aabye M.G., Ravn P., PrayGod G., Jeremiah K., Mugomela A., Jepsen M., et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009, 4:e4220.
44. Raby E., Moyo M., Devendra A., Banda J., De Haas P., Ayles H., et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008, 3:e2489.
45. Silva L.C., Silveira G.G., Arnone M., Romiti R., Geluk A., Franken K.C., et al. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area. Arch Dermatol Res 2010, 302:255-262.
46. Giardina A.R., Accardo-Palumbo A., Ciccia F., Ferrante A., Principato A., Impastato R., et al. Blocking TNF invitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?. Reumatismo 2009, 61:21-26.
47. Hamdi H., Mariette X., Godot V., Weldingh K., Hamid A.M., Prejean M.V., et al. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Res Ther 2006, 8:R114.
48. Keystone E.C., Papp K.A., Wobeser W. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. J Rheumatol 2011, 38:1234-1243.
49. The prevalence of pulmonary tuberculosis in a national survey across China in 2010. Zhonghua Jie He He Hu Xi Za Zhi 2012, 35:665-668. National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis.
50. Huang C.J., Zourdos M.C., Jo E., Ormsbee M.J. Influence of physical activity and nutrition on obesity-related immune function. Sci World J 2013, 2013:752071.
51. Marcos A., Nova E., Montero A. Changes in the immune system are conditioned by nutrition. Eur J Clin Nutr 2003, 57(Suppl. 1):S66-S69.
52. Marti A., Marcos A., Martinez J.A. Obesity and immune function relationships. Obes Rev 2001, 2:131-140.
53. Nieman D.C., Henson D.A., Nehlsen-Cannarella S.L., Ekkens M., Utter A.C., Butterworth D.E., et al. Influence of obesity on immune function. J Am Diet Assoc 1999, 99:294-299.
54. Jo E.K., Park J.K., Dockrell H.M. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 2003, 16:205-210.
55. Sahiratmadja E., Alisjahbana B., de Boer T., Adnan I., Maya A., Danusantoso H., et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007, 75:820-829.
56. Subronto Y.W., van Meijgaarden K.E., Geluk A., Arend S.M., Sunardi T., Franken K.L., et al. Interferon-gamma production in response to M. tuberculosis antigens in TB patients in Indonesia. Adv Exp Med Biol 2003, 531:249-260.
57. Lee Y.J., Lee J., Kim Y.Y., Won D.I., Cha S.I., Park J.Y., et al. Performance of whole-blood interferon-gamma release assay in patients admitted to the emergency department with pulmonary infiltrates. BMC Infect Dis 2011, 11:107.
58. Chee C.B., Barkham T.M., Khinmar K.W., Gan S.H., Wang Y.T. Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis. Eur J Clin Microbiol Infect Dis 2009, 28:667-670.
59. Cattamanchi A., Ssewenyana I., Davis J.L., Huang L., Worodria W., den Boon S., et al. Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis 2010, 10:75.
60. Jung J.Y., Lim J.E., Lee H.J., Kim Y.M., Cho S.N., Kim S.K., et al. Questionable role of interferon-gamma assays for smear-negative pulmonary TB in immunocompromised patients. J Infect 2012, 64:188-196.
61. Kim E.Y., Lim J.E., Jung J.Y., Son J.Y., Lee K.J., Yoon Y.W., et al. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 2009, 9:207.
62. Hadaya K., Bridevaux P.O., Roux-Lombard P., Delort A., Saudan P., Martin P.Y., et al. Contribution of interferon-gamma release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation. Transplantation 2013, 95:1485-1490.
63. Sauzullo I., Mengoni F., Scrivo R., Valesini G., Potenza C., Skroza N., et al. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis 2010, 14:834-840.
64. Faurholt-Jepsen D., Aabye M.G., Jensen A.V., Range N., Praygod G., Jeremiah K., et al. Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scand J Infect Dis 2014, 46:384-391.
65. Gan S.H., KhinMar K.W., Barkham T.M., Koh C.K., Shen L., Wang Y.T., et al. Interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in diabetes mellitus. Eur Respir J 2014, 44:805-808.
66. Syed Ahamed Kabeer B., Raman B., Thomas A., Perumal V., Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 2010, 5:e9051.
67. Tan C.K., Lai C.C., Chen H.W., Liao C.H., Chou C.H., Huang Y.T., et al. Enzyme-linked immunospot assay for interferon-gamma to support the diagnosis of tuberculosis in diabetic patients. Scand J Infect Dis 2010, 42:752-756.
68. Walsh M.C., Camerlin A.J., Miles R., Pino P., Martinez P., Mora-Guzman F., et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis 2011, 15:179-184.
69. Arend S.M., Thijsen S.F., Leyten E.M., Bouwman J.J., Franken W.P., Koster B.F., et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007, 175:618-627.
70. Beffa P., Zellweger A., Janssens J.P., Wrighton-Smith P., Zellweger J.P. Indeterminate test results of T-SPOT.TB performed under routine field conditions. Eur Respir J 2008, 31:842-846.
71. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367:1328-1334.
72. Kobashi Y., Sugiu T., Shimizu H., Ohue Y., Mouri K., Obase Y., et al. Clinical evaluation of the T-SPOT.TB test for patients with indeterminate results on the QuantiFERON TB-2G test. Intern Med 2009, 48:137-142.
73. Lai C.C., Tan C.K., Lin S.H., Liao C.H., Huang Y.T., Hsueh P.R. Diagnostic performance of whole-blood interferon-gamma assay and enzyme-linked immunospot assay for active tuberculosis'. Diagn Microbiol Infect Dis 2011, 71:139-143.
74. Lee J.Y., Choi H.J., Park I.N., Hong S.B., Oh Y.M., Lim C.M., et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006, 28:24-30.
75. Zellweger A., Zellweger J.P. Influence of pre-analytic conditions on the rate of indeterminate T-SPOT.TB tests. Eur Respir J 2011, 38:221-222.
76. Elzi L., Steffen I., Furrer H., Fehr J., Cavassini M., Hirschel B., et al. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infect Dis 2011, 11:319.
77. Chen J., Sun J., Zhang R., Liu L., Zheng Y., Shen Y., et al. T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency. AIDS Res Hum Retrovir 2011, 27:289-294.
78. Chkhartishvili N., Kempker R.R., Dvali N., Abashidze L., Sharavdze L., Gabunia P., et al. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia. BMC Infect Dis 2013, 13:513.
79. Costantino F., de Carvalho Bittencourt M., Rat A.C., Loeuille D., Dintinger H., Bene M.C., et al. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-gamma release assay results. J Rheumatol 2013, 40:1986-1993.
80. Banfield S., Pascoe E., Thambiran A., Siafarikas A., Burgner D. Factors associated with the performance of a blood-based interferon-gamma release assay in diagnosing tuberculosis. PLoS One 2012, 7:e38556.
81. Jeong S.J., Han S.H., Kim C.O., Baek J.H., Jin S.J., Ku N.S., et al. Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis-burden country. J Infect 2011, 62:347-354.
82. Lange B., Vavra M., Kern W.V., Wagner D. Indeterminate results of a tuberculosis-specific interferon-gamma release assay in immunocompromised patients. Eur Respir J 2010, 35:1179-1182.